REFERENCE
Havrilesky LJ, Secord AA, Darcy KM, Armstrong DK, Kulasingam S.Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group Study. Journal of Clinical Oncology 26: 4144-4150, No. 25, 1 Sep 2008
Rights and permissions
About this article
Cite this article
IP chemo for ovarian cancer - when does it pay off?. Pharmacoecon. Outcomes News 564, 8 (2008). https://doi.org/10.2165/00151234-200805640-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805640-00017